Not long to go now until the Final piece of data for the Phase 1 study to be released. Investors need to remember it has taken several years to get to where they are now and around $45 million. Multiple partnering opportunities to move ahead in the near term depending on the quality of release of data and how well they sell it .
Several Licensing partners seem to be eagerly awaiting the release of the final data. Also bullish to see Financial Investors interested in taking on risk with the funding of Phase 11 in return for a share of the asset which would reduce the need for further major dilution to current investors. The fact that the Market Cap is still trading in a $10 to $12 million range with high impact news to come makes this option even more appealing for Adalta limited.
This could be a reason the stock price is being held down so that interested Financial Investors can negotiate a better deal upon the release of final data. It is a different world when investing in this neck of the woods and if you think it is a level playing field you are living in the twilight zone.
1AD Price at posting:
2.2¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)